Lepzacitinib

Modify Date: 2025-08-25 15:36:20

Lepzacitinib Structure
Lepzacitinib structure
Common Name Lepzacitinib
CAS Number 2321488-47-3 Molecular Weight 355.39
Density N/A Boiling Point N/A
Molecular Formula C18H21N5O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Lepzacitinib


Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1].

 Names

Name Lepzacitinib

 Lepzacitinib Biological Activity

Description Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1].
Related Catalog
Target

JAK 1/3[1]

References

[1]. Anderson, et al. Preparation of substituted pyrrolopyridine compounds as JAK inhibitors. World Intellectual Property Organization, WO2019090158 A1 2019-05-09.

 Chemical & Physical Properties

Molecular Formula C18H21N5O3
Molecular Weight 355.39
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.